Heger Katharina A, Egger Daniel, Schmidinger Gerald, Skorpik Christian, Waldstein Sebastian M, Pircher Niklas
Department of Ophthalmology, Landesklinikum Mistelbach-Gänserndorf, Liechtensteinstraße 67, 2130, Mistelbach, Austria.
Karl Landsteiner University of Health Sciences, Krems, Austria.
Wien Med Wochenschr. 2025 May;175(7-8):175-185. doi: 10.1007/s10354-025-01077-9. Epub 2025 Apr 1.
Replacement of damaged corneal tissue with a clear transplant represents a viable solution for restoring vision in patients with corneal blindness. Among organ transplants, corneal transplantation occupies a unique status due to the cornea's lack of vascularization. This avascular nature makes immune compatibility testing between donor and recipient unnecessary and reduces the risk of transplant rejection, making corneal transplantation the most successful organ transplant procedure worldwide. Over the past century, corneal transplantation has undergone a transformative journey, evolving from full-thickness keratoplasty to highly refined techniques that selectively target individual diseased corneal layers. These modern lamellar approaches aim for faster recovery times and reduced rejection rates. The global demand for corneal graft tissue far exceeds the availability of donor tissue, leading to prolonged waiting times for patients in need of transplantation. Modern therapeutic strategies are expected to support or potentially even replace transplantation of corneal layers in the future.
用透明的移植片替换受损的角膜组织是恢复角膜盲患者视力的可行解决方案。在器官移植中,由于角膜无血管化,角膜移植占据着独特的地位。这种无血管的特性使得供体和受体之间无需进行免疫相容性检测,并降低了移植排斥的风险,这使得角膜移植成为全球最成功的器官移植手术。在过去的一个世纪里,角膜移植经历了变革性的历程,从全层角膜移植发展到能够选择性地针对单个患病角膜层的高度精细技术。这些现代的板层手术方法旨在缩短恢复时间并降低排斥率。全球对角膜移植组织的需求远远超过供体组织的供应量,导致需要移植的患者等待时间延长。预计未来现代治疗策略将支持甚至可能取代角膜层移植。